Cell-line dependency in cerebral organoid induction: cautionary observations in Alzheimer’s disease patient-derived induced pluripotent stem cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-6606

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Cell-line dependency in cerebral organoid induction: cautionary observations in Alzheimer’s disease patient-derived induced pluripotent stem cells ; volume:15 ; number:1 ; day:16 ; month:5 ; year:2022 ; pages:1-5 ; date:12.2022
Molecular brain ; 15, Heft 1 (16.5.2022), 1-5, 12.2022

Creator: Lee, Ju-Hyun
Yoo, Geon
Choi, Juhyun
Park, Si-Hyung
Shin, Hyogeun
Prasad, Renuka
Lee, Yeunehee
Ahn, Mee Ryung
Cho, Il-Joo
Sun, Woong

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13041-022-00928-5

URN: urn:nbn:de:101:1-2022072021543434328038

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lee, Ju-Hyun
Yoo, Geon
Choi, Juhyun
Park, Si-Hyung
Shin, Hyogeun
Prasad, Renuka
Lee, Yeunehee
Ahn, Mee Ryung
Cho, Il-Joo
Sun, Woong
SpringerLink (Online service)

Other Objects (12)

Simple modeling of familial Alzheimer’s disease using human pluripotent stem cell-derived cerebral organoid technology

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink

Single-cell multiregion dissection of Alzheimer’s disease

Alzheimer’s disease, dementia, and stem cell therapy

Integrated multimodal cell atlas of Alzheimer’s disease

Characterizing dysregulations via cell-cell communications in Alzheimer’s brains using single-cell transcriptomes

Single-cell-led drug repurposing for Alzheimer’s disease

Neuroepigenomics in Alzheimer’s disease: The single cell ADds

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease

Simple modeling of familial Alzheimer’s disease using human pluripotent stem cell-derived cerebral organoid technology

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink

Single-cell multiregion dissection of Alzheimer’s disease

Alzheimer’s disease, dementia, and stem cell therapy

Integrated multimodal cell atlas of Alzheimer’s disease

Characterizing dysregulations via cell-cell communications in Alzheimer’s brains using single-cell transcriptomes

Single-cell-led drug repurposing for Alzheimer’s disease

Neuroepigenomics in Alzheimer’s disease: The single cell ADds

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease

Simple modeling of familial Alzheimer’s disease using human pluripotent stem cell-derived cerebral organoid technology

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink

Single-cell multiregion dissection of Alzheimer’s disease

Alzheimer’s disease, dementia, and stem cell therapy

Integrated multimodal cell atlas of Alzheimer’s disease

Characterizing dysregulations via cell-cell communications in Alzheimer’s brains using single-cell transcriptomes

Single-cell-led drug repurposing for Alzheimer’s disease

Neuroepigenomics in Alzheimer’s disease: The single cell ADds

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Cell-line dependency in cerebral organoid induction: cautionary observations in Alzheimer’s disease patient-derived induced pluripotent stem cells

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Simple modeling of familial Alzheimer’s disease using human pluripotent stem cell-derived cerebral organoid technology

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink

Single-cell multiregion dissection of Alzheimer’s disease

Alzheimer’s disease, dementia, and stem cell therapy

Integrated multimodal cell atlas of Alzheimer’s disease

Characterizing dysregulations via cell-cell communications in Alzheimer’s brains using single-cell transcriptomes

Single-cell-led drug repurposing for Alzheimer’s disease

Neuroepigenomics in Alzheimer’s disease: The single cell ADds

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease

Simple modeling of familial Alzheimer’s disease using human pluripotent stem cell-derived cerebral organoid technology

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink

Single-cell multiregion dissection of Alzheimer’s disease

Alzheimer’s disease, dementia, and stem cell therapy

Integrated multimodal cell atlas of Alzheimer’s disease

Characterizing dysregulations via cell-cell communications in Alzheimer’s brains using single-cell transcriptomes

Single-cell-led drug repurposing for Alzheimer’s disease

Neuroepigenomics in Alzheimer’s disease: The single cell ADds

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease

Simple modeling of familial Alzheimer’s disease using human pluripotent stem cell-derived cerebral organoid technology

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink

Single-cell multiregion dissection of Alzheimer’s disease

Alzheimer’s disease, dementia, and stem cell therapy

Integrated multimodal cell atlas of Alzheimer’s disease

Characterizing dysregulations via cell-cell communications in Alzheimer’s brains using single-cell transcriptomes

Single-cell-led drug repurposing for Alzheimer’s disease

Neuroepigenomics in Alzheimer’s disease: The single cell ADds

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease

Related objects

Reset password